Meeting
2023 ASCO Annual Meeting
Analysis of ATM germline mutations in solid tumors from Chinese patients.
Authors
Tao Fu
China-Japan Friendship Hospital, Beijing, China
Tao Fu , Yaping Zhao , Didi Guo , Siqi Chen , Tiantian Han , Ran Ding , Wanglong Deng , Fanfeng Bu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10586)
DOI
10.1200/JCO.2023.41.16_suppl.10586
Abstract #
10586
Poster Bd #
219
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Molecular genetic sequencing of neuroendocrine tumors of the gastrointestinal tract.
First Author: Alexandra Androsova
Poster
2016 Gastrointestinal Cancers Symposium
Tumor profiling of 431 pancreatic tumors from elderly patients.
First Author: Joanne Xiu
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
First Author: Rachna T. Shroff
Poster
2023 ASCO Annual Meeting
Multi-omic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes.
First Author: Brian Warnecke